CN103054901A - 透析液及其相关方法和系统 - Google Patents
透析液及其相关方法和系统 Download PDFInfo
- Publication number
- CN103054901A CN103054901A CN2012105744771A CN201210574477A CN103054901A CN 103054901 A CN103054901 A CN 103054901A CN 2012105744771 A CN2012105744771 A CN 2012105744771A CN 201210574477 A CN201210574477 A CN 201210574477A CN 103054901 A CN103054901 A CN 103054901A
- Authority
- CN
- China
- Prior art keywords
- pyrophosphate
- type compound
- dialysis
- acid salt
- pyrophosphoric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51517403P | 2003-10-28 | 2003-10-28 | |
| US60/515,174 | 2003-10-28 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2004800390401A Division CN101094681A (zh) | 2003-10-28 | 2004-10-27 | 透析液及其相关方法和系统 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103054901A true CN103054901A (zh) | 2013-04-24 |
Family
ID=34572815
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012105744771A Pending CN103054901A (zh) | 2003-10-28 | 2004-10-27 | 透析液及其相关方法和系统 |
| CNA2004800390401A Pending CN101094681A (zh) | 2003-10-28 | 2004-10-27 | 透析液及其相关方法和系统 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2004800390401A Pending CN101094681A (zh) | 2003-10-28 | 2004-10-27 | 透析液及其相关方法和系统 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070148258A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1682077A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4838139B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101249707B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN103054901A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004287440A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0416088A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2544235C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005044189A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8187467B2 (en) * | 2003-12-30 | 2012-05-29 | Ajay Gupta | Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion |
| EP2206504A4 (en) | 2007-10-05 | 2014-02-12 | Univ Chiba Nat Univ Corp | STABLE IONIC BICARBONATE MEDICINES SOLUTION |
| US7658952B2 (en) * | 2007-10-11 | 2010-02-09 | Baxter International Inc. | Dialysis solutions containing pyrophosphates |
| ES2332636B1 (es) * | 2008-08-06 | 2011-02-10 | Universitat De Les Illes Balears | Composicion de liquido de dialisis. |
| JP5258448B2 (ja) * | 2008-08-12 | 2013-08-07 | 扶桑薬品工業株式会社 | 透析用製剤 |
| AU2015200995B2 (en) * | 2010-04-23 | 2016-09-08 | Vantive Health Gmbh | Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy |
| EP2560663B1 (en) * | 2010-04-23 | 2016-06-22 | Baxter International Inc. | Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy |
| CN102517635B (zh) * | 2012-01-12 | 2014-12-24 | 中国科学院新疆理化技术研究所 | 化合物锂钾磷氧和锂钾磷氧晶体及其制备方法 |
| EP2862583A1 (en) * | 2013-10-17 | 2015-04-22 | Gambro Lundia AB | Perm selective membrane for treating vascular calcification in chronic hemodialysis patients |
| DE102015007842A1 (de) * | 2015-06-18 | 2016-12-22 | Fresenius Medical Care Deutschland Gmbh | Dialyselösung |
| US20200009163A1 (en) * | 2017-03-06 | 2020-01-09 | University Of Houston System | Polyphosphates as inhibitors of calcium crystallization |
| IT201700085412A1 (it) * | 2017-07-26 | 2019-01-26 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare |
| IT201700089258A1 (it) | 2017-08-02 | 2019-02-02 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di carenza di ferro |
| MX2021003653A (es) | 2018-10-11 | 2021-06-23 | Sanifit Therapeutics S A | Inositol fosfatos para el tratamiento de calcificacion ectopica. |
| IT201900007329A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia |
| IT201900007326A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari |
| IT201900007311A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati |
| CN118416279B (zh) * | 2024-04-23 | 2025-09-02 | 大连医科大学附属第二医院 | 一种预防血管钙化的动静脉内瘘外用敷料及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9903442A3 (en) * | 1996-02-08 | 2001-11-28 | Warner Lambert Co | Anticalculus dentifrice containing highly soluble pyrophosphate |
| AU736053B2 (en) * | 1996-12-31 | 2001-07-26 | Ajay Gupta | Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients |
| US6689275B1 (en) * | 1996-12-31 | 2004-02-10 | Ajay Gupta | Method and pharmaceutical composition for replacing iron losses in dialysis patients |
| US6779468B1 (en) * | 1997-08-07 | 2004-08-24 | Ajay Gupta | Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients |
| EP1009452A4 (en) * | 1997-08-07 | 2004-03-31 | Ajay Gupta | WATER-SOLUBLE VITAMINS AND DIALYSIS SOLUTION CONTAINING NUTRIENTS |
| JP2003519183A (ja) * | 2000-01-04 | 2003-06-17 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 心臓および動脈の石灰化を抑制する低用量ビスホスホネートの使用 |
| JP2002249433A (ja) * | 2000-12-19 | 2002-09-06 | Sumitomo Pharmaceut Co Ltd | 血管石灰化抑制剤 |
| US20040241249A1 (en) | 2001-06-18 | 2004-12-02 | Tina Sampalis | Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases arthritis, skin cancer diabetes, premenstrual syndrome and transdermal transport |
| US6524788B1 (en) * | 2001-11-02 | 2003-02-25 | Thomas L. Cantor | Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
| US8187467B2 (en) * | 2003-12-30 | 2012-05-29 | Ajay Gupta | Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion |
-
2004
- 2004-10-27 AU AU2004287440A patent/AU2004287440A1/en not_active Abandoned
- 2004-10-27 BR BRPI0416088-6A patent/BRPI0416088A/pt not_active IP Right Cessation
- 2004-10-27 US US10/577,607 patent/US20070148258A1/en not_active Abandoned
- 2004-10-27 EP EP04818294A patent/EP1682077A4/en not_active Withdrawn
- 2004-10-27 CN CN2012105744771A patent/CN103054901A/zh active Pending
- 2004-10-27 WO PCT/US2004/035541 patent/WO2005044189A2/en not_active Ceased
- 2004-10-27 JP JP2006538192A patent/JP4838139B2/ja not_active Expired - Fee Related
- 2004-10-27 CA CA2544235A patent/CA2544235C/en not_active Expired - Fee Related
- 2004-10-27 KR KR1020067010395A patent/KR101249707B1/ko not_active Expired - Fee Related
- 2004-10-27 CN CNA2004800390401A patent/CN101094681A/zh active Pending
Non-Patent Citations (4)
| Title |
|---|
| AJAY GUPTA,ET AL: "Dialysate iron therapy:Infusion of soluble ferric pyrophophate via the dialysate during hemodialysis", 《KIDNEY INTERNATIONAL》 * |
| H. FLEISCH,ET AL: "Inhibiton of Aortic Calcification by means of Pyrophosphate and Polyphosphates", 《NATURE》 * |
| HERBERT FLEISCH,ET AL: "Mechanism of Calcilication:Inhibitory Role of Pyrophosphate", 《NATURE》 * |
| R. GRAHAM,ET AL: "Pyrophosphate and Diphosphonates in Calcium Metabolism and Theri Possible Role in Renal Failure", 《ARCH. INTERN. MED.》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1682077A2 (en) | 2006-07-26 |
| EP1682077A4 (en) | 2009-07-01 |
| CA2544235C (en) | 2013-12-10 |
| WO2005044189A2 (en) | 2005-05-19 |
| JP4838139B2 (ja) | 2011-12-14 |
| JP2007523056A (ja) | 2007-08-16 |
| US20070148258A1 (en) | 2007-06-28 |
| CN101094681A (zh) | 2007-12-26 |
| AU2004287440A1 (en) | 2005-05-19 |
| BRPI0416088A (pt) | 2007-01-02 |
| KR101249707B1 (ko) | 2013-04-05 |
| KR20070014110A (ko) | 2007-01-31 |
| CA2544235A1 (en) | 2005-05-19 |
| WO2005044189A3 (en) | 2007-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4838139B2 (ja) | 透析液並びに透析液に関連した方法及びシステム | |
| Dhar et al. | Effects of hematin in hepatic porphyria: further studies | |
| JP2007523056A5 (cg-RX-API-DMAC7.html) | ||
| US5474992A (en) | Method of treatment with pharmaceutical composition for renal disorder and a dialysis solution for extracorporeal hemodialysis | |
| EA018245B1 (ru) | Органические соединения трехвалентного железа фармацевтического качества, их применение и способы их получения | |
| CN106588928A (zh) | 新型七环化合物,其合成,活性评价及应用 | |
| US20160106713A1 (en) | Nitric oxide scavengers | |
| CN115379841A (zh) | 治疗呼吸系统病症的trpc6抑制剂 | |
| JP2023510865A (ja) | 血管脂肪腫の処置のための組成物 | |
| KR20190003319A (ko) | 섬유화증 예방, 개선 또는 치료용 조성물 | |
| KR20210020930A (ko) | 노화 세포에 의해 유발되거나 매개되는 병태의 임상 관리에서의 사용 및 암 치료를 위한 bcl 패밀리 길항제인 아실 설폰아마이드 | |
| AU735980B2 (en) | A method of treating liver disease and like indications with vasodilating agents | |
| CN113521060B (zh) | 鱼针草内酯抗新型冠状病毒的用途 | |
| TWI754260B (zh) | 魚針草內酯抗新型冠狀病毒之用途 | |
| US12403125B2 (en) | Use of Ovatodiolide against SARS-CoV-2 | |
| TW200306811A (en) | Medicinal compositions for inhibiting tryptase | |
| RU2358731C2 (ru) | Cci-779 для лечения лимфомы из мантийных клеток | |
| KR20190085946A (ko) | 트리시클릭 유도체 또는 이의 약학적으로 허용 가능한 염을 포함하는 허혈성 급성 신 손상 예방 또는 치료용 약학적 조성물 | |
| MXPA06004730A (en) | Dialysates and methods and systems related thereto | |
| KR100379596B1 (ko) | 구연산칼륨을 주제로 한 요로결석치료제의 제조방법 | |
| CN103417554A (zh) | 一种抗肿瘤的药物组合物及其应用 | |
| CN112999233A (zh) | 一类来源于赤芍的单萜苷类化合物及其制法和应用 | |
| Nagura et al. | Me3221, a surmountable angiotensin at1-receptor antagonist, prevents hypertensive complications in aged stroke-prone spontaneously hypertensive rats | |
| KR20060066176A (ko) | 데커신 및/또는 데커시놀 안젤레이트, 또는 데커신및/또는 데커시놀 안젤레이트를 유효성분으로 하는당귀추출물을 포함하는 신기능 치료제 조성물 | |
| KR20120119014A (ko) | 경련성 질환 치료 및 예방용 약학조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130424 |